HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Toshinobu Kazui Takayuki Nakajima Kazuaki Ishihara Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Kazui, T. Articles by Kawazoe, K. Search for Related Content PubMed PubMed Citation Articles by Kazui, T. Articles by Kawazoe, K. Related Collections Valve disease

Combined Aortic and Mitral Valve Repair

Department of Cardiovascular Surgery, Iwate Medical University, Morioka, Iwate, Japan

For reprint information contact: Toshinobu Kazui, MD Tel: 81 019 651 5111 Fax: 81 019 624 8384 email: t-kazui{at}pf6.so-net.ne.jp Department of Cardiovascular Surgery, Memorial Heart Center, Iwate Medical University, 1-2-1 chuoudori Morioka city, Iwate, Japan.

Six patients, median age 63.3 years (range, 54 to 68 years), underwent concomitant mitral and aortic valve repair from January 2000 to August 2001. Surgical reports and general clinical data were reviewed retrospectively. All patients had degenerative valvular disease, although one patient also had annuloaortic ectasia. There were no surgical complications. The 30 day survival rate was 100%, and the New York Heart Association classification score improved from 2.2 (range, 1 to 2) preoperative, to 1.0 (all patients) postoperatively (p = 0.03) As measured by intraoperative transesophageal echocardiography, the left ventricular end-diastolic diameter decreased from 6.0 cm (range, 5.4 to 6.3 cm) to 4.7 cm (range, 4.0 to 5.2 cm) and the left ventricular end-systolic diameter decreased from 3.7 cm (range, 3.4 to 4.1cm) to 3.1 cm (range, 2.9 to 3.7 cm). No patient developed endocarditis, thromboembolism or hemorrhage. There was no valve related morbidity during a 1 year follow up. Double valve repair is an acceptable alternative to valve replacement in selected patients with some types of valvular disease. Longer term follow up with greater numbers of patients is needed.